313 related articles for article (PubMed ID: 29326317)
21. Cost-effectiveness analysis of intracameral cefuroxime use for prophylaxis of endophthalmitis after cataract surgery.
Sharifi E; Porco TC; Naseri A
Ophthalmology; 2009 Oct; 116(10):1887-96.e1. PubMed ID: 19560825
[TBL] [Abstract][Full Text] [Related]
22. Endophthalmitis Reduction with Intracameral Moxifloxacin Prophylaxis: Analysis of 600 000 Surgeries.
Haripriya A; Chang DF; Ravindran RD
Ophthalmology; 2017 Jun; 124(6):768-775. PubMed ID: 28214101
[TBL] [Abstract][Full Text] [Related]
23. Prophylactic antibiotics for postcataract surgery endophthalmitis: a systematic review and network meta-analysis of 6.8 million eyes.
Kato A; Horita N; Namkoong H; Nomura E; Masuhara N; Kaneko T; Mizuki N; Takeuchi M
Sci Rep; 2022 Oct; 12(1):17416. PubMed ID: 36258003
[TBL] [Abstract][Full Text] [Related]
24. Intracameral cefuroxime: prophylaxis of postoperative endophthalmitis after cataract surgery.
Keating GM
Drugs; 2013 Feb; 73(2):179-86. PubMed ID: 23338537
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of intracameral cefuroxime in preventing endophthalmitis after cataract surgery Ten-year comparative study.
García-Sáenz MC; Arias-Puente A; Rodríguez-Caravaca G; Bañuelos JB
J Cataract Refract Surg; 2010 Feb; 36(2):203-7. PubMed ID: 20152598
[TBL] [Abstract][Full Text] [Related]
26. Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: potential role of moxifloxacin.
O'Brien TP; Arshinoff SA; Mah FS
J Cataract Refract Surg; 2007 Oct; 33(10):1790-800. PubMed ID: 17889778
[TBL] [Abstract][Full Text] [Related]
27. Safety of intracameral cefuroxime in pars plana vitrectomy.
Neffendorf JE; Kumaran N; Sandinha T; Wong RS; Laidlaw DAH; Williamson TH
Eye (Lond); 2021 Sep; 35(9):2601-2606. PubMed ID: 33219339
[TBL] [Abstract][Full Text] [Related]
28. Intracameral cefuroxime in the prevention of postoperative endophthalmitis: an experience from Hong Kong.
Ng AL; Tang WW; Li PS; Li KK
Graefes Arch Clin Exp Ophthalmol; 2016 Oct; 254(10):1987-1992. PubMed ID: 27553051
[TBL] [Abstract][Full Text] [Related]
29. Prophylactic intracameral cefuroxime. Efficacy in preventing endophthalmitis after cataract surgery.
Montan PG; Wejde G; Koranyi G; Rylander M
J Cataract Refract Surg; 2002 Jun; 28(6):977-81. PubMed ID: 12036639
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of the use of intracameral cefuroxime as prophylaxis in cataract surgery.
Fontanet JM; March F; Morón A; Gorgas MQ
Farm Hosp; 2012; 36(3):170-2. PubMed ID: 22118765
[No Abstract] [Full Text] [Related]
31. Intracameral antibiotics for prophylaxis of postoperative endophthalmitis in Australia: a review.
Lipsky L; Barrett G
Clin Exp Ophthalmol; 2019 May; 47(4):537-541. PubMed ID: 30345591
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of Intracameral Moxifloxacin Endophthalmitis Prophylaxis at Aravind Eye Hospital.
Haripriya A; Chang DF; Namburar S; Smita A; Ravindran RD
Ophthalmology; 2016 Feb; 123(2):302-308. PubMed ID: 26522705
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness and Safety of an Intracameral Injection of Cefuroxime for the Prevention of Endophthalmitis After Cataract Surgery With or Without Perioperative Capsular Rupture.
Daien V; Papinaud L; Gillies MC; Domerg C; Nagot N; Lacombe S; Daures JP; Carriere I; Villain M
JAMA Ophthalmol; 2016 Jul; 134(7):810-6. PubMed ID: 27136069
[TBL] [Abstract][Full Text] [Related]
34. Toxicities of and inflammatory responses to moxifloxacin, cefuroxime, and vancomycin on retinal vascular cells.
Miyake H; Miyazaki D; Shimizu Y; Sasaki SI; Baba T; Inoue Y; Matsuura K
Sci Rep; 2019 Jul; 9(1):9745. PubMed ID: 31278356
[TBL] [Abstract][Full Text] [Related]
35. Intracameral cefuroxime injection at the end of cataract surgery to reduce the incidence of endophthalmitis: French study.
Barreau G; Mounier M; Marin B; Adenis JP; Robert PY
J Cataract Refract Surg; 2012 Aug; 38(8):1370-5. PubMed ID: 22814043
[TBL] [Abstract][Full Text] [Related]
36. Impact of prophylactic intracameral moxifloxacin on post-cataract surgery endophthalmitis: data from a tertiary eye care facility in rural India.
Shenoy P; Goh EJH; Kashikar R; Kohli GM; Sachdeva M; Naman V; Sood D; Bhatia P; Sen P; Agrawal R; Sen A
Int Ophthalmol; 2021 Aug; 41(8):2729-2736. PubMed ID: 33821388
[TBL] [Abstract][Full Text] [Related]
37. Acute Endophthalmitis after Cataract Surgery: Clinical Characteristics and the Role of Intracameral Antibiotic Prophylaxis.
de Geus SJR; Hopman J; Brüggemann RJ; Klevering BJ; Crama N
Ophthalmol Retina; 2021 Jun; 5(6):503-510. PubMed ID: 32956857
[TBL] [Abstract][Full Text] [Related]
38. Intracameral cefuroxime and moxifloxacin used as endophthalmitis prophylaxis after cataract surgery: systematic review of effectiveness and cost-effectiveness.
Linertová R; Abreu-González R; García-Pérez L; Alonso-Plasencia M; Cordovés-Dorta LM; Abreu-Reyes JA; Serrano-Aguilar P
Clin Ophthalmol; 2014; 8():1515-22. PubMed ID: 25152613
[TBL] [Abstract][Full Text] [Related]
39. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors.
Endophthalmitis Study Group, European Society of Cataract & Refractive Surgeons
J Cataract Refract Surg; 2007 Jun; 33(6):978-88. PubMed ID: 17531690
[TBL] [Abstract][Full Text] [Related]
40. [Endophthalmitis after cataract surgery: epidemiology, clinical features and antibiotic prophylaxis].
García-Sáenz MC; Arias-Puente A; Rodríguez-Caravaca G; Andrés Alba Y; Bañuelos Bañuelos J
Arch Soc Esp Oftalmol; 2010 Aug; 85(8):263-7. PubMed ID: 21130941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
